Financing ·
Actuate Therapeutics raises $9.96M net from selling 30.99M shares and warrants at $0.71 per unit
ACTUActuate Therapeutics, Inc.
Actuate Therapeutics closed an underwritten public offering of 30,985,900 shares of common stock accompanied by warrants to purchase up to 15,492,950 additional shares. The securities were priced at $0.71 per unit, consisting of two shares and one warrant. Net proceeds totaled approximately $9.96 million after deducting underwriting discounts and offering expenses. The warrants carry an exercise price of $0.45 per share and expire five years from issuance. The company intends to use the net proceeds for working capital and general corporate purposes.